31-May-24 | 31-May-23 | 31-May-22 | 31-May-21 | 31-May-20 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Australia | 84.70 | 10% | 99.80 | 11% | 96.20 | 10% | 128.00 | 15% | 91.90 | 14% |
Europe | 101.30 | 12% | 116.20 | 12% | 112.90 | 11% | 108.00 | 13% | 89.00 | 14% |
Japan | 78.50 | 9% | 99.30 | 10% | 98.50 | 10% | 68.70 | 8% | 46.60 | 7% |
Singapore | 72.40 | 8% | 68.80 | 7% | 74.10 | 8% | 75.30 | 9% | 57.00 | 9% |
UK | n/a | n/a | 322.00 | 34% | 365.30 | 37% | 346.80 | 41% | 257.70 | 39% |
US | 143.20 | 17% | 140.90 | 15% | 128.60 | 13% | 15.10 | 2% | 23.50 | 4% |
Unanalysed | 372.30 | 44% | 102.70 | 11% | 106.40 | 11% | 105.00 | 12% | 92.00 | 14% |
Total | 852.40 | 100% | 949.70 | 100% | 982.00 | 100% | 846.90 | 100% | 657.70 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 400.80 | 100% | 449.90 | 100% | 477.00 | 100% | 446.00 | 100% | 295.90 | 100% |
Total | 400.80 | 100% | 449.90 | 100% | 477.00 | 100% | 446.00 | 100% | 295.90 | 100% |
31-May-24 | 31-May-23 | 31-May-22 | 31-May-21 | 31-May-20 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Exchange traded derivatives | 681.00 | 80% | 782.00 | 82% | 817.30 | 83% | 8.30 | 1% | 18.40 | 3% |
OTC leveraged derivatives | n/a | n/a | 137.10 | 15% | 121.20 | 12% | 790.30 | 94% | 617.20 | 95% |
Stock trading and investments | 22.80 | 3% | 22.70 | 2% | 33.80 | 3% | 38.70 | 5% | 13.60 | 2% |
Unanalysed | 148.60 | n/a | 7.90 | n/a | 9.70 | n/a | 9.60 | n/a | 8.50 | n/a |
Total | 852.40 | 100% | 949.70 | 100% | 982.00 | 100% | 846.90 | 100% | 657.70 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 400.80 | n/a | 449.90 | n/a | 477.00 | n/a | 446.00 | n/a | 295.90 | n/a |
Total | 400.80 | n/a | 449.90 | n/a | 477.00 | n/a | 446.00 | n/a | 295.90 | n/a |
You are here: research